Publication:
Editorial: Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches.

Simple item page
dc.contributor.authorEgea, Javier
dc.contributor.authorGonzalez-Rodriguez, Agueda
dc.contributor.authorGomez-Guerrero, Carmen
dc.contributor.authorMoreno, Juan Antonio
dc.contributor.funderFIS/FEDER
dc.contributor.funderSpanish Ministry of Economy and Competitiveness
dc.contributor.funderCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)
dc.date.accessioned2023-02-08T14:41:05Z
dc.date.available2023-02-08T14:41:05Z
dc.date.issued2019-09-06
dc.description.abstractOxidative stress and inflammation are pathological processes involved in the genesis and development of numerous disorders. Nuclear factor erythroid 2–related factor 2 (Nrf2) is a transcription factor that regulates the expression of multiple antioxidant and cytoprotective proteins and enzymes, thus playing a key role in protection against oxidative damage. There is a growing interest in understanding the specific role of Nrf2 in the development and progression of diseases as well as design novel approaches targeting Nrf2 to prevent and/or retard tissue injury
dc.description.versionSi
dc.identifier.citationEgea J, González-Rodríguez Á, Gómez-Guerrero C, Moreno JA. Editorial: Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches. Front Pharmacol. 2019 Oct 4;10:1149
dc.identifier.doi10.3389/fphar.2019.01149
dc.identifier.issn1663-9812
dc.identifier.pmcPMC6787767
dc.identifier.pmid31636562
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787767/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fphar.2019.01149/pdf
dc.identifier.urihttp://hdl.handle.net/10668/15089
dc.journal.titleFrontiers in pharmacology
dc.journal.titleabbreviationFront Pharmacol
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number3
dc.publisherFrontiers Research Foundation
dc.pubmedtypeEditorial
dc.relation.projectIDCP14/00008
dc.relation.projectIDCP16/00014
dc.relation.projectIDRYC-2017-22369
dc.relation.projectIDCP16/00017
dc.relation.projectIDPI15/00448
dc.relation.publisherversionhttps://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2019.01149/full
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectNrf2
dc.subjectDisease
dc.subjectInflammation
dc.subjectInjury
dc.subjectOxidative stress
dc.subject.decsAntioxidantes
dc.subject.decsEstrés oxidativo
dc.subject.decsFactor 2 relacionado con NF-E2
dc.subject.decsInflamación
dc.subject.decsRegulación de la expresión génica
dc.subject.decsTriamcinolona
dc.subject.meshAntioxidants
dc.subject.meshNF-E2-related factor 2
dc.subject.meshOxidative stress
dc.subject.meshInflammation
dc.subject.meshGene expression regulation
dc.subject.meshTriamcinolone
dc.titleEditorial: Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number10
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC6787767.pdf
Size:
701.88 KB
Format:
Adobe Portable Document Format
Download

Collections

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Universitario Reina Sofía

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía